Court Documents
This official website is maintained by the Settlement Administrator for is In Re: Suboxone (Buprenorphine Hydrochloride and Nalaxone) Antitrust Litigation, 2:13-md-02445-MSG pending in the United States District Court for the Eastern District of Pennsylvania.
- 2015-04-13 End Payor Plaintiffs’ Second Consolidated Amended Class Action Complaint
- 2019-09-27 Order re End-Payor and Direct Plaintiffs Motion for Class Certification
- 2023-08-14 Settlement Agreement
- 2023-08-19 Declaration of Kenneth A. Wexler ISO Unopposed Motion for Preliminary Approval of End Payor Settlement and For Other Relief
- 2023-08-28 Amended Order Nunc Pro Tunc August 21, 2023 Granting End-Payor Plaintiffs’ Unopposed Motion for Preliminary Approval of End Payor Settlement and For Other Relief
- 2023-09-05 End Payor Plaintiffs’ Motion for (1) Award of Attorneys’ Fees, (2) Reimbursement of Litigation Expenses, and (3) Payment of Service Awards to the Class Representatives
- 2023-09-05 Memorandum of Law ISO EPPs’ Motion for (1) Award of Attorneys’ Fees, (2) Reimbursement of Litigation Expenses, and (3) Payment of Service Awards to the Class Representatives
- Plan of Allocation updated to conform to Settlement, Class Notice, and Claim Forms 9-26-2023
Note: These documents are in PDF format. To view the
documents, you will need Adobe Acrobat Reader
on your computer or other internet-enabled device.
